
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2022 following the close of regular trading on Tuesday, May 3, 2022. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day.
This call will be webcast live and can be accessed at the company’s website at vareximaging.com/news. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company’s website and a replay of the call will be available from May 3rd through May 17th at 877-660-6853 from anywhere in the U.S. or 201-612-7415 from non-U.S. locations. The replay conference call access code is 13728899.
The listen-only webcast link is: https://services.choruscall.com/mediaframe/webcast.html?webcastid=4tQUvghx
About Varex
Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices and imaging software in their systems to detect, diagnose, protect and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,100 people located in North America, Europe, and Asia. For more information visit vareximaging.com.
For Information Contact:
Christopher Belfiore
Director of Investor Relations
Varex Imaging Corporation
801.973.1566 | christopher.belfiore@vareximaging.com
Articles

VAREX SCHEDULES FIRST QUARTER FISCAL YEAR 2023 EARNINGS RELEASE AND CONFERENCE CALL
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2023 following the close of regular trading on Tuesday, January 31, 2023

VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2022
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter of fiscal year 2022.

VAREX SCHEDULES FOURTH QUARTER AND FISCAL YEAR 2022 EARNINGS RELEASE AND CONFERENCE CALL
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and full fiscal year 2022 following the close of regular trading on Tuesday, November 15, 2022.

Varex Imaging at ASNT 2022
Varex Imaging will attend the 2022 ASNT conference in Nashville, Tennessee.

VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2022
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2022.

Varex Imaging at the International Security Expo at Olympia London
Varex Imaging will attend the International Security Expo at Olympia London.

VAREX SCHEDULES THIRD QUARTER FISCAL YEAR 2022 EARNINGS RELEASE AND CONFERENCE CALL
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2022 following the close of regular trading on Tuesday, August 2, 2022.

Varex Imaging at ECR 2022
Varex Imaging Corporation will attend the 2022 European Congress of Radiology (ECR) in Vienna this summer.

VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2022
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2022.

Varex Imaging at the 34th Control Trade Show
Varex Imaging Corporation will attend the 34th annual Control international trade fair in Stuttgart, Germany

Varex Announces Partial Redemption of Senior Secured Notes
Varex Imaging Corporation today announced the partial redemption of $27 million of its 7.875% senior secured notes due 2027, which represents 10% of the outstanding principal amount of the notes.

Varex to Present at Oppenheimer's 32nd Annual Healthcare Virtual Investor Conference
Varex Imaging Corporation announced today that it is scheduled to present at Oppenheimer’s 32nd Annual Healthcare virtual investor conference.